Article
Pharmaceutical Executive
Pharmaceutical Executive
Author(s):
Brussels-Lack of intellectual property protection is not causing the erosion of European pharma, reports the European Generics Association.
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.